Long-term outcome of hepatitis C infection after bone marrow transplantation
about
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Hepatitis C virus and allogeneic stem cell transplantation still matters!Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesGene expression and hepatitis C virus infectionGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation.Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients.Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups.Late effects of blood and marrow transplantation.Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.Long-term follow-up after allogeneic stem cell transplantationThe history of the "natural history" of hepatitis C (1968-2009).National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage aRecommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationReview article: management of hepatic disease following haematopoietic cell transplant.Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor studyLiver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C.Refractory Ascites with Liver Fibrosis Developed in Late Phase Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Patients.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Late complications after hematopoietic stem cell transplantation.Hepatitis C and non-Hodgkin lymphoma: the clinical perspective.Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy.Challenges in managing hepatitis C virus infection in cancer patients.Optimal management of patients with chronic hepatitis C and comorbidities.The oncologic burden of hepatitis C virus infection: A clinical perspective.A review of late complications of allogeneic hematopoietic stem cell transplantations.How I treat hepatitis C virus infection in patients with hematologic malignancies.Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation.Successful therapy with Ledipasvir/Sofosbuvir for hepatitis C reactivation in a hematopoietic stem cell transplant recipient.Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant.Hepatitis C in haematological patients.Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection.Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.Hepatitis B and C in hematopoietic stem cell transplantPrevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipientsRecommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationRecommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
P2860
Q27478329-C7F17AC3-E184-43A1-86D4-ED2E8435B917Q27487854-3101B7F7-F45C-4005-8AF6-C952B1AD0E9AQ27487855-CBB1E173-096A-4091-8370-07A2EC6801B2Q27488345-C5F3FEE4-16BA-4726-974A-16AC921CCC2EQ28388806-23AEC760-A679-40D0-B0A1-D60ED029B764Q30417045-31725E94-7146-4331-864C-5BA019EE49E6Q33263439-D94CCFCB-025F-470A-82B5-F8AAE4BBAD61Q33367606-9F3163CE-8E4A-4C27-B31C-8A32515F5CC5Q33559091-A90BDC76-95EE-43AB-8BF6-B18F551EFDB2Q33574136-CCC90DA0-EAEC-440B-9079-037D3CFC6716Q34036696-44923EFC-337D-4DC1-ACF0-5AB68EC12C84Q35104794-5FB2D557-D1FF-423D-8128-72FBAB24144CQ35216592-BBF7B814-9018-46F0-9DE7-438E4FB16973Q35549037-550076BA-16D6-47AE-83BE-5BDD2552C6CFQ35757247-718F0DA4-E865-430A-B0C7-295B606967C6Q36347299-BB131319-18D6-4EC5-91B2-411AC36FE832Q36555955-BF187B87-C406-462D-B673-650F17994B74Q36790040-F20596D7-206B-4E98-A8F7-89E8048F5F89Q36951682-DC4B5015-2DFD-4E19-9289-98F0C03B0097Q37067589-61B8E476-1A2C-4607-8012-5E8CA292CD07Q37128102-6FAEF8B9-6366-48E9-A182-65B6F6C6E8D0Q37150434-0C38FA10-689E-437D-92C9-04FCA45A9ABAQ37810122-6DECBB35-B2A4-4237-93BA-DA1C94C66A49Q37961614-2F5E478F-1DE4-4BAE-B97E-D5616E1A492CQ38062943-2F35E703-DB71-4378-B466-DC536CA7FD15Q38198615-CA2DA7B3-D275-4441-B614-9A0365E4E43DQ38295819-0B3E3E51-D6FD-4C0A-A5B2-7D0C6AC642DFQ39418450-233636B1-03C3-4283-AAF3-926B905DD679Q40115697-2D93C4CB-2636-490F-8D58-2522B9945287Q40604797-DAFDA3E8-06F6-4280-A6F3-7E2E042D2918Q40610203-31A4E487-2F2E-4CE1-86D6-C0B51B3F90A9Q40747468-3026961A-932E-411F-ADDA-925DE9A3E8D0Q40943696-D2C5E41C-5F95-4E38-BCCD-13C12B7F68CDQ41218951-DACF77B1-9FE8-4A57-BBF8-BFC35CAFE40DQ41609788-C7C5A7F7-A72F-4758-B9CF-DBB241BDCB97Q41678851-42CA06A5-5FA2-4C97-AF7C-131A46F8F7ECQ41769561-AC6142EB-AEC7-4087-AF7D-FA67A362CE13Q41888846-513B2898-D4D6-4650-A7D8-B5A2AE008690Q42111313-6FA47252-BD71-4029-B856-1D2F77CB6B37Q42230889-A3C11870-0049-4AFD-8EFF-C069C1A87790
P2860
Long-term outcome of hepatitis C infection after bone marrow transplantation
description
im März 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 23 October 2003
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2004
@uk
name
Long-term outcome of hepatitis C infection after bone marrow transplantation
@en
Long-term outcome of hepatitis C infection after bone marrow transplantation
@nl
type
label
Long-term outcome of hepatitis C infection after bone marrow transplantation
@en
Long-term outcome of hepatitis C infection after bone marrow transplantation
@nl
prefLabel
Long-term outcome of hepatitis C infection after bone marrow transplantation
@en
Long-term outcome of hepatitis C infection after bone marrow transplantation
@nl
P2093
P50
P1433
P1476
Long-term outcome of hepatitis C infection after bone marrow transplantation
@en
P2093
Agnès Devergie
Catherine Scieux
Gérard Socié
Hélène Espérou
Lionel Adès
Patricia Ribaud
Patrick Marcellin
Richard Traineau
Régis Peffault de Latour
Tarik Asselah
P304
P356
10.1182/BLOOD-2003-06-2145
P407
P577
2003-10-23T00:00:00Z